Association Between Baseline Anti-Cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients With RA
posted on 2021-05-05, 16:39authored byAdis journals on behalf of, Leslie R. Harrold, Joshua Bryson, Thomas Lehman, Joe Zhuo, Sheng Gao, Xue Han, Amy Schrader, Sabrina Rebello, Dimitrios A. Pappas, Tanya Sommers, Joel M. Kremer
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).